DNM2 and idiopathic pulmonary fibrosis: 5% CTRL) (Figure 2B), reflecting in part the molecular function (Figure 2C) with the extracellular matrix structural constituent most represented in IPF patients (9% IPF patients vs 5.9% CTRL) as well as the cytoskeletal protein binding (5.6% IPF patients vs 3% CTRL).